HomeSHTDF • OTCMKTS
add
Sinopharm Group Co Ltd
Nakaraang pagsara
$1.97
Sakop ng taon
$1.97 - $2.95
Market cap
63.04B HKD
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 147.46B | -5.13% |
Gastos sa pagpapatakbo | 6.38B | -2.07% |
Net na kita | 2.28B | -9.16% |
Net profit margin | 1.55 | -4.32% |
Kita sa bawat share | — | — |
EBITDA | 5.57B | -12.42% |
Aktuwal na % ng binabayarang buwis | 21.74% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 43.33B | 26.05% |
Kabuuang asset | 429.58B | 2.85% |
Kabuuang sagutin | 307.15B | 0.84% |
Kabuuang equity | 122.43B | — |
Natitirang share | 3.12B | — |
Presyo para makapag-book | 0.08 | — |
Return on assets | 2.96% | — |
Return on capital | 5.84% | — |
Cash Flow
Net change in cash
| (CNY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 2.28B | -9.16% |
Cash mula sa mga operasyon | 6.49B | 346.39% |
Cash mula sa pag-invest | -1.29B | -269.35% |
Cash mula sa financing | -602.70M | -425.16% |
Net change in cash | 4.59B | 374.61% |
Malayang cash flow | -22.56B | 29.73% |
Tungkol
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Itinatag
2003
Website
Mga Empleyado
113,635
